Page 2 - Leon Office News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cullinan Oncology (NASDAQ:CGEM – Get Rating) and Kiromic BioPharma (NASDAQ:KRBP – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Analyst Recommendations This is a breakdown of recent ratings […]

Genfit (NASDAQ:GNFT – Get Rating) and Kiromic BioPharma (NASDAQ:KRBP – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Risk and Volatility Genfit has a beta of 1.36, suggesting […]